Basics Black Diamond Therapeutics, Inc. IPO Date: January 31, 2020 Sector: Healthcare Industry: Biotech Market Cap: $167.39M Activated in VL: True Average Daily Range Avg Daily Range: $0.37 | 3.69% Avg Daily Range (30 D): $0.09 | 3.38% Avg Daily Range (90 D): $0.08 | 3.40% Institutional Daily Volume Avg Daily Volume: .66M Avg Daily Volume (30 D): .79M Avg Daily Volume (90 D): .96M Trade Size Avg Trade Size (Sh.): 133 Avg Trade Size (Sh.) (30 D): 165 Avg Trade Size (Sh.) (90 D): 176 Institutional Trades Total Inst.Trades: 370 Avg Inst. Trade: $1.83M Avg Inst. Trade (30 D): $3.32M Avg Inst. Trade (90 D): $3.32M Avg Inst. Trade Volume: .16M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.28M Avg Closing Trade (30 D): $7.95M Avg Closing Trade (90 D): $7.95M Avg Closing Volume: 172.61K     News Aug 7, 2025 @ 12:23 PM Black Diamond (BDTX) Q2 Loss Narrows 47% Source: Jesterai Aug 1, 2025 @ 4:21 PM Clarus (CLAR) Q2 Loss Beats Estimates Source: Jesterai Mar 19, 2025 @ 11:00 AM Servier and Black Diamond Therapeutics AnnounceÂÂ... Source: N/A Jan 29, 2025 @ 6:00 PM BRAF Inhibitors Market to Register Incremental Gro... Source: Delveinsight Nov 5, 2024 @ 1:00 PM Black Diamond Therapeutics Reports Third Quarter 2... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $.25 $-.19 $1 Diluted EPS $.23 $-.19 $.98 Revenue $ 70M $ M $ 70M Gross Profit $ $ $ Net Income / Loss $ 14.44M $ -10.56M $ 56.54M Operating Income / Loss $ 4.71M $ -13.42M $ 54.53M Cost of Revenue $ $ $ Net Cash Flow $ -2.82M $ -68.43M $ 61.99M PE Ratio 12.96